AB Sciex has been launched as a new company combining the two halves of the AB Sciex mass spectrometry joint venture into an integrated organisation. AB Sciex intends to use its new operating structure to increase speed to market in developing new solutions and expanding service and support to enable the scientific community to continue its increasing use of mass spectrometry for a broader range of applications.

Currently, more than 12,000 AB Sciex mass spectrometry systems are deployed in virtually every major laboratory around the world, spanning the pharmaceutical, biotechnology, food safety testing and environmental analysis fields, as well as hospitals and academic institutions. The company also offers software applications and reagents such as iTRAQ and mTRAQ.

Laura Lauman, joint president of AB Sciex, said “The vision that led to the creation of AB Sciex is that this integrated company will be able to shape the future of mass spectrometry in ways far greater than what we have already achieved as the market leader in this industry. By bringing our former joint venture together as a single operating company, AB Sciex will be able to create a new level of energy, achieve greater customer focus and satisfaction, and further accelerate innovation to keep pace with the dynamic needs of the life science industry.”

Her joint president, Andy Boorn, added “AB Sciex is the go-to company for the most robust, rugged and reliable analytical tools available in the marketplace today. When scientists think about AB Sciex, I want them to think about first: first in innovation, first in new technologies, first to bring solutions to help them solve their problems. Our continuous advancements in developing leading-edge technologies enable us to make meaningful contributions to the health and safety of people around the world.”

User Rating: / 10
PoorBest